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Abstract Re-transfusion of drainage blood is widely used in orthopedic surgery,
but objective evidence of the efficacy of re-transfusion of drainage blood in view
of post-transfusion survival of RBC has not been given so far. With this study we
wanted to evaluate the efficacy and safety of transfusion of drainage blood collected
with HandyVac autotransfusion system. In 7 patients red cells in drainage blood
were labeled with biotin and percentage of labeled red cells in circulation were de-
termined immediately after re-transfusion, and during 10 days after surgery. To
assess further unwanted side-effects of re-transfusion of drainage blood potassium
and free hemoglobin were determined in the collected blood. Ten days after re-
transfusion at mean 78.9% of drainage-blood derived RBC were found in circulation.
Free hemoglobin in drainage blood ranged from 16.8 to 59.2 mg/dL; potassium in
drainage blood ranged from 3.84 to 4.52 mmol/L. Our results suggest that re-trans-
fusion of drainage blood collected with HandyVac autotransfusion system is an
efficient procedure that seems to be safe in view of free hemoglobin and potassium
in the product.
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Transfusion of drainage blood has been practiced
for many years. This trend to avoid loss of
autologous blood is driven by fear of transfusion-
associated transmission of infectious diseases1
and immunomodulation,2,3 but also by economic
considerations in a time of declining willingness
to donate blood and stringent quality assurance
criteria which decrease the percentage of donated
blood products finally released. Some aspects of
re-transfusion of drainage blood have been inves-
tigated, principally concerning safety4 and clinical
efficacy,5 but the actual intended purpose for
re-transfusion of drainage blood, namely provision
of viable red cells to circulation, is an objective
that has not been investigated extensively. For
erythrocyte concentrates a post-transfusion 24-h-
survival of about 75% of transfused red blood cells
is required, depending on the age of the prod-
ucts.6 During collection of drainage blood red cells
are exposed to several stress factors possibly af-
fecting viability and consequently influencing
post-transfusion persistence in circulation. Firstly,
drainage blood is not collected through an opti-
mized venous access, but flows through the
wound; secondly, a negative pressure is used in
the collection system to draw blood; further blood
cells are collected at room temperature for sever-
al hours before re-transfusion or further manipu-
lation. All these factors may have impact on the
integrity of erythrocyte membranes7 and thus,
transfusion of drainage blood is still lacking verifi-
cation of efficacy. We therefore studied post-
transfusion persistence in circulation of red cells
that had been collected in a drainage system
and were re-transfused after 5 h collection time.
Materials and methods
Patient characteristics
Seven patients (2 males, 5 females; age 52e81
years, no hematological disorders) who underwent
planned total knee arthroplasty were included in
the study after informed consent. The study had
been approved by the institutional ethics
committee.
Drainage blood collection systems
HandyVAC ATS (Unomedical a/s, Alleroed, Denmark)
collects drainage blood from the patient intoa blood-compatible bag, using low negative pres-
sure administered by a bellow. Reinfusion is
performed through a 150/50/10 mm triple cas-
cade filter to remove unwanted impurities and
aggregates.8
Labeling and detection of labeled red cells
After collection of drainage blood for 5 h subse-
quently to surgery, 120e150 mL drainage blood
was taken for labeling, and the remaining drainage
blood was re-transfused within 6 h after insertion
of the drain. To label the red cells, drainage blood
was washed twice with PBS (4 C) and incubated
for 30 min at 22 C with the labeling reagent
(10 mg Sulfo NHS BiotinC 350 mL PBS at room tem-
perature), following a method described earlier.9
After incubation nonattached biotin was removed
from the red cell suspension by double washing
with PBS and resuspension with saline. The result-
ing suspension of labeled red cells was transfused
through a transfusion set.
Detection of labeled red cells was performed by
flow cytometry with Avidin-FITC (BD Pharmingen).
Venous blood samples were collected 15 min, 24,
72, and 120 h, and 10 days after retransfusion
with EDTA as anticoagulant. Before staining blood
samples were diluted 1:200 and washed twice
(1000! g) to remove free biotin in serum. Red
cells (0.8e1! 106) were resuspended in 80 ml PBS
and incubated with 3.5 mg Avidin FITC for 15 min
in the dark at room temperature. Labeled erythro-
cytes were washed twice with PBS (1000! g) and
measured by FACSCalibur (BD Pharmingen). Red
cells were gated on forward scatter versus side
scatter properties to exclude debris and doublets.
The mean fluorescence intensity (FITC) of red cells
was determined using a density dot plot of log fluo-
rescence 1 versus log side scatter. The unspecific
staining of the relevant negative control was also
validated and subtracted. The percentage of la-
beled and unlabeled red cells was calculated.
Patients’ reactions to re-transfusion
During transfusion and further hospital stay body
temperature was measured daily. Urine was ex-
amined for macrohemoglobinuria.
Statistics
Data were described by percentages, ranges and
graphically. Geometric mean was used for averag-
ing of fractions of labeled RBC.
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Total RBC, free hemoglobin and potassium
in re-transfused drainage blood
Total drainage blood volumes of 550e1000 mL with
hematocrit 0.23e0.44 were collected, correspond-
ing to 125e328 mL red cells. Free hemoglobin in
the collected drainage blood ranged from 16.8 to
59.2 mg/dL, and potassium from 3.84 to
4.52 mmol/L, resulting in 107.4e251.3 mg free
hemoglobin and 1.6e3.3 mmol potassium in the
transfused drainage blood. Details are shown in
Table 1.
Survival of RBC retransfused
Percentages of biotinylated RBC in samples drawn
from the patients after transfusion were 1.58e
4.3% and served as basic values (100%) to observe
changes. The fraction of labeled RBC decreased in
patients that did not receive other red cell trans-
fusions than drainage blood 67e90% during 10 days
after surgery. In patient a who was transfused with
one unit of autologous PRBC (storage time 30 days)
we found an increased percentage of labeled cells
from 100% to 131% after 5 days. Patients 3 and
a were not available for control on day 10. Details
are shown in Table 2.
Transfusion reactions
No unusual change of body temperature was
observed in patients. No patient showed macro-
hemoglobinuria during hospital stay.
Discussion
Aim of this study was to evaluate the efficacy of
transfusion of drainage blood collected withHandyVac. Our data show that this collection sys-
tem provides remarkable amounts of red cells to
be re-transfused, that the re-transfusion of drain-
age blood does not harm the patient by free hemo-
globin or potassium, and that the system provides
RBC to circulation that survive even better than
stored RBC do, according to literature.
This study reveals a remarkably high 24-h post
transfusion recovery for the salvaged biotin-
labeled cells. Red cells in re-transfused drainage
blood represented at mean 14.2% of circulating red
cells immediately after transfusion, and also are
comparable to 0.5e1.5 units of PRBC.
Red cells salvaged from drainage blood and
retransfused are slowly removed from circulation.
We found that 10 days after transfusion at mean
78.9% of transfused RBC can be found in circula-
tion. Storage conditions for erythrocyte concen-
trates have been evaluated to provide RBC of
which at least 75% (‘‘X’’ in Fig. 1) can be found
in circulation 24 h after transfusion.6 Our results
show that drainage blood-derived red cells can
be found at much higher percentages 24 h after re-
transfusion, what we ascribe to minimal storage
lesions. The improved survival of RBC from drain-
age blood can be seen in the patient that received
additional transfusion. Patient a was given 1 unit
of 30-day-stored autologous PRBC between the
end of collection of drainage blood and re-transfu-
sion; thus, only ‘‘fresh’’ red cells that had not
been stored in the pre-donated PRBC were collected
in drainage blood. The increase of the percentage
of labeled drainage-blood derived RBC illustrates
the accelerated sequestration of non-labeled
cells, as we think, RBC from the autologous blood
unit which had been stored for 30 days. This
finding calls for further investigation of the post-
transfusion survival of pre-stored red cells.
Collection of blood in a drainage system causes
significant hemolysis with resulting high levels of
free hemoglobin. Free hemoglobin in re-transfused
drainage blood collected with HandyVac rangedTable 1 Patients and drainage blood characteristics
Number Patient data Drainage blood data










1 52 M 6.1 700 34.4 52 3.85
2 76 W 4.0 1000 26.6 16.8 4.52
3 63 W 4.7 700 28.9 49.5 4.41
4 76 W 4.5 750 43.7 53.5 4.2
5 61 W 5.1 550 22.8 59.2 3.91
6 81 M 4.0 550 24.0 25.7 3.84
a 57 W 3.9 600 24.0 23.9 4.17
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than that of stored PRBC that contain up to
112 mg/dL free hemoglobin after 42 days of stor-
age.10 As expected, study patients did not show
hemoglobinuria after retransfusion, as hemoglo-
binuria seems to occur at free hemoglobin levels
of at least 1.5 g/L.6 We did not determine free he-
moglobin in patients after retransfusion, but it can
be calculated that free hemoglobin in the patients
would have been between 0.027 and 0.052 g/L,
well below the limit to pass through the kidney.





















Figure 1 Change of percentage of biotinylated red
cells from base value (100%) after re-transfusion of
drainage blood during 10 days of observation. The
dashed line shows patient a that had received one addi-
tional transfusion before retransfusion of drainage
blood. ‘‘X’’ marks the minimum level of 75% 24-h-post-
transfusion survival that has been established for trans-
fusion of previously stored red cells.
Table 2 Percentage of labeled red cells after
re-transfusion of drainage blood (day 0) and on post-
operative days 1e10
Patient Day
0 1 3 5 10
1 2.99 2.74 2.20 1.94 1.99
2 3.02 2.99 2.18 2.14 2.13
3 1.58 1.54 1.55 1.43
4 3.40 3.39 2.95 3.01 2.81
5 2.64 2.66 2.66 2.5 2.3
6 4.11 4.00 3.81 3.72 3.71
a 4.30 4.36 4.52 5.62
Patient a was transfused previously stored PRBC and thus
was analyzed separately; patients 3 and a were not available
for control on post-operative day 10.Besides release of hemoglobin, erythrocyte
damage also releases remarkable amounts of
potassium. Potassium in drainage blood collected
with HandyVac ranged from 3.84 to 4.52 mmol/L,
well within the physiological range. Thus, no
potassium-associated acute events should be
expected after transfusion of drainage blood.
Our results show that transfusion of RBC col-
lected with HandyVac autotransfusion system is
an efficient procedure that does not put patients
at risk by hemolysis in the product.
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